跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23 条关于
“RhodoLED”
全部
23
临床试验
6
药物
0
机构
1
资讯
16
去年
Biofrontera Acquires Full US Rights to Ameluz and RhodoLED, Secures $11M Funding
11个月前
Biofrontera Inc. Completes $11M Asset Acquisition of Ameluz and RhodoLED US Rights
去年
Biofrontera Inc. Negotiates Strategic Partnership Changes with German Parent Company
9个月前
Biofrontera Submits FDA Application for Ameluz-PDT in Superficial Basal Cell Carcinoma Treatment
4天前
FDA Approves Biofrontera's Ameluz Red-Light PDT for Superficial Basal Cell Carcinoma
去年
Biofrontera's Ameluz Demonstrates High Efficacy in Phase III sBCC Trial
去年
Biofrontera Announces Database Lock for Phase 3 sBCC Study of Ameluz®-PDT
去年
Biofrontera's Ameluz Demonstrates Success in Phase III sBCC Trial, Stock Surges
去年
Biofrontera Completes Phase 2b Trial of Ameluz for Moderate to Severe Acne Treatment
去年
FDA Approves Increased Dosage for Biofrontera's Ameluz in Actinic Keratosis Treatment
第 1 页,共 2 页
上一页
下一页